Clinical trial
Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responders
NCT06554873 is registered in ClinicalTrials.gov with Rose Research Center, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responders
- Lead sponsor
- Rose Research Center, LLC
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 29, 2024
- Completion date
- December 9, 2025
- Enrollment
- 150 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
harm reduction, smoking cessation